Synphate Co.,Ltd. The board of directors of Rmakhamhaeng Hospital Public Company Limited held on January 9th, 2020 passed the following resolution the acquisition of Vibharam Co.,Ltd.’s new ordinary shares
voting rights in such matter, consisting of the following persons: 1) Mr. Suthichai Chirathivat Chairman 2) Mr. Suthikiati Chirathivat Director 3) Mr. Sudhisak Chirathivat Director 4) Mr. Sudhitham
disposition of assets to Trust as the following: (A) Approved the disposition of assets by approving the following related transactions: Approved the Company to sell sub-leasehold right at the date when the
as following results: Revenue In the year 2019, the Company and its subsidiaries had total revenue of 910.7 MB, decreased from the year 2018 in the amount of 18.6 MB or 2.0 percent (Domestic sales
increase are as follows: 1. Total revenues was Baht 17,971.82 million, a decrease of Baht 563.35 million or down by 3.0% over the same period of last year, which comprises of the following details: - Revenue
could not be recorded in profit/loss statement because methyl ester plant 2 was under testing run for commercial operation. While, Methyl ester price increased following an increase in crude palm oil
million baht while the same period last year recorded the net profit in the amount of 1,825.80 million baht, decreased of 481.81 million baht or 26.39% because of the following; 1. In the first quarter of
implementation to contain the spread of COVID-19, the Company and its subsidiaries announced the following measures and assistances being employed. - Commercial business: during April-May 2020, the Company would
Public Company Limited and its subsidiaries had the operation results for the 6-month period ended 30 June 2020 with the following details: unit: THB million 2020 2019 Change (THB mill.) Change (%) Revenue
company and subsidiary for 2nd quarter of 2020 with a net profit of Baht 15.38 million when compared with the same period of year 2019 with a net profit of Baht 34.66 million due to the following reasons. 1